- 2025-04-12 17:36(S)-TCO-PEG2-Maleimide
- 2025-04-12 17:36HBV Seq1 aa:141-151 147318-53-4
- 2025-04-12 17:362-O-trans-p-Coumaroylalphitolic acid 67911-63-1
- 2025-04-12 17:36TMV-IN-13
- 2025-04-12 17:36Alunacedase alfa (HrsACE2; GSK 2586881) 2416824-55-8
- 2025-04-12 17:365-epi-Jinkoheremol 2567930-96-3
- 2025-04-12 17:36hCA/VEGFR-2-IN-5
- 2025-04-12 17:36Asp-Asp-Asp-Asp-Asp-Asp TFA
- 2025-04-12 17:36ET receptor antagonist 1
- 2025-04-12 17:365,7,8-Trimethoxycoumarin 60796-65-8
- 2025-04-12 17:36Berkeleylactone E 122211-62-5
- 2025-04-12 17:36EGFR kinase inhibitor 3 2922402-03-5
- 2025-04-12 17:36Stearyl gallate 10361-12-3
- 2025-04-12 17:362-Hydroxy-4-methylbenzenesulphonic acid ammonium 79093-71-3
- 2025-04-12 17:36Amibegron 121524-08-1
- 2025-04-12 17:36IND 1316 1888473-12-8
- 2025-04-12 17:36Multi-kinase inhibitor 3 2648279-76-7
- 2025-04-12 17:36DBCO-PEG4-VA-PBD 2241644-09-5
- 2025-04-12 17:36Androgen receptor antagonist 12 6605-17-0
- 2025-04-12 17:36RSV L-protein-IN-5 851658-28-1
